Markus Honickel

Sufficient Thrombin Generation Despite 95% Hemodilution: An In Vitro Experimental Study.

Journal: Journal of clinical medicine

Published: October 27, 2020

Prothrombin Complex Concentrate-induced Disseminated Intravascular Coagulation Can Be Prevented by Coadministering Antithrombin in a Porcine Trauma Model.

Journal: Anesthesiology

Published: June 11, 2019

Transient or extended reversal of apixaban anticoagulation by andexanet alfa is equally effective in a porcine polytrauma model.

Journal: British journal of anaesthesia

Published: November 03, 2018

Volume replacement strategies do not impair the binding of dabigatran to idarucizumab: Porcine model of hemodilution.

Journal: PloS one

Published: June 18, 2018

Evaluation of combined idarucizumab and prothrombin complex concentrate treatment for bleeding related to dabigatran in a lethal porcine model of double trauma.

Journal: Transfusion

Published: June 12, 2018

The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran Elimination.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: March 15, 2018

Survival of HeartMate II Patients Despite Cessation of Anticoagulation　- Outcomes and Hemostatic Analysis.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: December 15, 2017

Reversal of dabigatran by intraosseous or intravenous idarucizumab in a porcine polytrauma model.

Journal: British journal of anaesthesia

Published: September 06, 2017

Reversing Dabigatran Anticoagulation with Prothrombin Complex Concentrate versus Idarucizumab as Part of Multimodal Hemostatic Intervention in an Animal Model of Polytrauma.

Journal: Anesthesiology

Published: September 01, 2017

The Reversal of Direct Oral Anticoagulants in Animal Models.

Journal: Shock (Augusta, Ga.)

Published: May 05, 2017

Dose requirements for idarucizumab reversal of dabigatran in a lethal porcine trauma model with continuous bleeding.

Journal: Thrombosis and haemostasis

Published: November 02, 2016

Septic porcine blood does not further activate coagulation during in vitro membrane oxygenation.

Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Published: June 24, 2016

Sufficient Thrombin Generation Despite 95% Hemodilution: An In Vitro Experimental Study.

Sufficient Thrombin Generation Despite 95% Hemodilution: An In Vitro Experimental Study.

Prothrombin Complex Concentrate-induced Disseminated Intravascular Coagulation Can Be Prevented by Coadministering Antithrombin in a Porcine Trauma Model.

Prothrombin Complex Concentrate-induced Disseminated Intravascular Coagulation Can Be Prevented by Coadministering Antithrombin in a Porcine Trauma Model.

Transient or extended reversal of apixaban anticoagulation by andexanet alfa is equally effective in a porcine polytrauma model.

Transient or extended reversal of apixaban anticoagulation by andexanet alfa is equally effective in a porcine polytrauma model.

Volume replacement strategies do not impair the binding of dabigatran to idarucizumab: Porcine model of hemodilution.

Volume replacement strategies do not impair the binding of dabigatran to idarucizumab: Porcine model of hemodilution.

Evaluation of combined idarucizumab and prothrombin complex concentrate treatment for bleeding related to dabigatran in a lethal porcine model of double trauma.

Evaluation of combined idarucizumab and prothrombin complex concentrate treatment for bleeding related to dabigatran in a lethal porcine model of double trauma.

The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran Elimination.

The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran Elimination.

Survival of HeartMate II Patients Despite Cessation of Anticoagulation - Outcomes and Hemostatic Analysis.

Survival of HeartMate II Patients Despite Cessation of Anticoagulation - Outcomes and Hemostatic Analysis.

Reversal of dabigatran by intraosseous or intravenous idarucizumab in a porcine polytrauma model.

Reversal of dabigatran by intraosseous or intravenous idarucizumab in a porcine polytrauma model.

Reversing Dabigatran Anticoagulation with Prothrombin Complex Concentrate versus Idarucizumab as Part of Multimodal Hemostatic Intervention in an Animal Model of Polytrauma.

Reversing Dabigatran Anticoagulation with Prothrombin Complex Concentrate versus Idarucizumab as Part of Multimodal Hemostatic Intervention in an Animal Model of Polytrauma.

The Reversal of Direct Oral Anticoagulants in Animal Models.

The Reversal of Direct Oral Anticoagulants in Animal Models.

Dose requirements for idarucizumab reversal of dabigatran in a lethal porcine trauma model with continuous bleeding.

Dose requirements for idarucizumab reversal of dabigatran in a lethal porcine trauma model with continuous bleeding.

Septic porcine blood does not further activate coagulation during in vitro membrane oxygenation.

Septic porcine blood does not further activate coagulation during in vitro membrane oxygenation.

Survival of HeartMate II Patients Despite Cessation of Anticoagulation　- Outcomes and Hemostatic Analysis.

Survival of HeartMate II Patients Despite Cessation of Anticoagulation　- Outcomes and Hemostatic Analysis.